{"id":"https://openalex.org/W2033095142","doi":"https://doi.org/10.1111/j.1399-5618.2008.00634.x","title":"The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment","display_name":"The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatment","publication_year":2008,"publication_date":"2008-11-18","ids":{"openalex":"https://openalex.org/W2033095142","doi":"https://doi.org/10.1111/j.1399-5618.2008.00634.x","mag":"2033095142","pmid":"https://pubmed.ncbi.nlm.nih.gov/19594505"},"language":"en","primary_location":{"id":"doi:10.1111/j.1399-5618.2008.00634.x","doi":"https://doi.org/10.1111/j.1399-5618.2008.00634.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1399-5618.2008.00634.x","pdf_url":null,"source":{"id":"https://openalex.org/S58085280","display_name":"Bipolar Disorders","issn_l":"1398-5647","issn":["1398-5647","1399-5618"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029742430","display_name":"Philip D. Harvey","orcid":"https://orcid.org/0000-0002-9501-9366","observed_orcids":["https://orcid.org/0000-0002-9501-9366","https://orcid.org/0000-0001-7813-4701"]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Philip D Harvey","raw_affiliation_strings":["epartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Woodruff Memorial Building, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA. philipdharvey1@cs.com","Emory University School of Medicine, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"epartment of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Woodruff Memorial Building, 101 Woodruff Circle, Suite 4000, Atlanta, GA 30322, USA. philipdharvey1@cs.com","institution_ids":["https://openalex.org/I150468666"]},{"raw_affiliation_string":"Emory University School of Medicine, Atlanta, GA","institution_ids":["https://openalex.org/I150468666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104312159","display_name":"Jean Endicott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388891851","display_name":"New York State Psychiatric Institute","ror":"https://ror.org/04aqjf708","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4388891851"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jean M Endicott","raw_affiliation_strings":["New York State Psychiatric Institute, Biometrics Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York State Psychiatric Institute, Biometrics Research Institute","institution_ids":["https://openalex.org/I4388891851"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066553937","display_name":"Antony D Loebel","orcid":"https://orcid.org/0000-0002-7591-8647","observed_orcids":["https://orcid.org/0000-0002-7591-8647"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I4210140088","display_name":"Sumitomo Dainippon Pharma (United States)","ror":"https://ror.org/04vwbmb32","country_code":"US","type":"company","lineage":["https://openalex.org/I31591830","https://openalex.org/I4210140088"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antony D Loebel","raw_affiliation_strings":["Pfizer, Inc., New York, NY","now at Dainippon Sumitomo Pharma America, Inc., Fort Lee, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Inc., New York, NY","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"now at Dainippon Sumitomo Pharma America, Inc., Fort Lee, NJ, USA","institution_ids":["https://openalex.org/I4210140088"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5029742430"],"corresponding_institution_ids":["https://openalex.org/I150468666"],"apc_list":{"value":4730,"currency":"USD","value_usd":4730},"apc_paid":null,"fwci":1.168,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.78855409,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"10","issue":"8","first_page":"900","last_page":"906"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13283","display_name":"Mental Health Research Topics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9940000176429749},{"id":"https://openalex.org/keywords/manic-episodes","display_name":"manic episodes","score":0.8799999952316284},{"id":"https://openalex.org/keywords/mixed-states","display_name":"mixed states","score":0.9399999976158142},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8759999871253967},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9909999966621399},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":1.0},{"id":"https://openalex.org/keywords/symptom-dimensions","display_name":"symptom dimensions","score":0.5709999799728394},{"id":"https://openalex.org/keywords/mania-severity","display_name":"mania severity","score":0.6230000257492065},{"id":"https://openalex.org/keywords/schizophrenia-comparison","display_name":"schizophrenia comparison","score":0.49300000071525574}],"concepts":[{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.7166353464126587},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.7002578377723694},{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.649101972579956},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6481608152389526},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5569223165512085},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5522140264511108},{"id":"https://openalex.org/C2778609679","wikidata":"https://www.wikidata.org/wiki/Q4915474","display_name":"Bipolar I disorder","level":5,"score":0.5377047657966614},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.5299830436706543},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.4956568479537964},{"id":"https://openalex.org/C2777089681","wikidata":"https://www.wikidata.org/wiki/Q4340609","display_name":"Young Mania Rating Scale","level":5,"score":0.47341710329055786},{"id":"https://openalex.org/C2778528637","wikidata":"https://www.wikidata.org/wiki/Q4967025","display_name":"Brief Psychiatric Rating Scale","level":3,"score":0.44355571269989014},{"id":"https://openalex.org/C2780468923","wikidata":"https://www.wikidata.org/wiki/Q7431050","display_name":"Schedule for Affective Disorders and Schizophrenia","level":3,"score":0.4301931858062744},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.4235593378543854},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4021967351436615},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.28813502192497253},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.27797746658325195},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.15061533451080322},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.06110045313835144},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.0},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010343","descriptor_name":"Patient Admission","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011594","descriptor_name":"Psychometrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1399-5618.2008.00634.x","doi":"https://doi.org/10.1111/j.1399-5618.2008.00634.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1399-5618.2008.00634.x","pdf_url":null,"source":{"id":"https://openalex.org/S58085280","display_name":"Bipolar Disorders","issn_l":"1398-5647","issn":["1398-5647","1399-5618"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar Disorders","raw_type":"journal-article"},{"id":"pmid:19594505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19594505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bipolar disorders","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8299999833106995}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W153750880","https://openalex.org/W1972156069","https://openalex.org/W1974702488","https://openalex.org/W1977023318","https://openalex.org/W2001515160","https://openalex.org/W2009642661","https://openalex.org/W2039358758","https://openalex.org/W2059787115","https://openalex.org/W2071794120","https://openalex.org/W2071858378","https://openalex.org/W2079033779","https://openalex.org/W2099549036","https://openalex.org/W2124270063","https://openalex.org/W2131552807","https://openalex.org/W2133810719","https://openalex.org/W2148889846","https://openalex.org/W2153381163","https://openalex.org/W2159155203","https://openalex.org/W2161282771"],"related_works":["https://openalex.org/W2036653749","https://openalex.org/W3036030404","https://openalex.org/W2084790954","https://openalex.org/W2074814851","https://openalex.org/W2025189599","https://openalex.org/W2171604848","https://openalex.org/W2141300297","https://openalex.org/W2157790804","https://openalex.org/W2075349061","https://openalex.org/W1977711233"],"abstract_inverted_index":{"BACKGROUND:":[0],"While":[1],"the":[2,18,32,62,71,97,104,111,134,151,164,178,182],"factor":[3,63,141,211],"structure":[4,33,64,72],"of":[5,34,36,59,73,125,245],"clinical":[6],"symptoms":[7,35,75,246],"in":[8,26,197,202,232,240],"schizophrenia":[9],"has":[10],"been":[11,248],"examined":[12,31],"and":[13,44,103,116,136,150,160,192,205,215,255],"provided":[14],"crucial":[15],"information":[16,24],"about":[17],"illness,":[19],"there":[20],"is":[21,200,224],"much":[22],"less":[23],"available":[25],"bipolar":[27,37,92,198],"disorder.":[28],"This":[29],"study":[30,77],"disorder":[38,199],"at":[39,76,163],"an":[40,203],"unmedicated":[41,165,206],"baseline":[42,166],"assessment":[43],"after":[45,65],"double-blind":[46,126],"treatment":[47,66,256],"with":[48,56,82,96,133,174,208],"ziprasidone,":[49],"haloperidol,":[50],"or":[51,87],"placebo.":[52],"We":[53],"hypothesized,":[54],"consistent":[55],"recent":[57],"studies":[58],"schizophrenia,":[60,241],"that":[61,171,229],"would":[67],"be":[68,235],"similar":[69],"to":[70,250],"untreated":[74],"baseline.":[78],"METHODS:":[79],"Hospitalized":[80],"patients":[81,129,162],"manic":[83,161,193,216],"(n":[84,89],"=":[85,90],"363)":[86],"mixed":[88,159,191,214],"71)":[91],"episodes":[93],"were":[94,130],"rated":[95,132],"Hamilton":[98],"Depression":[99],"Rating":[100,106],"Scale":[101,107],"(HAM-D)":[102],"Mania":[105],"[(MRS);":[108],"derived":[109],"from":[110,237],"Schedule":[112],"for":[113,158,190,213],"Affective":[114],"Disorders":[115],"Schizophrenia":[117],"-":[118],"Change":[119],"Bipolar":[120],"Scale].":[121],"After":[122],"21":[123],"days":[124],"treatment,":[127,219],"all":[128],"again":[131],"MRS":[135,152],"HAM-D.":[137],"RESULTS:":[138],"Exploratory":[139],"orthogonal":[140],"analysis":[142],"(varimax":[143],"rotation)":[144],"including":[145],"both":[146],"HAM-D":[147],"total":[148],"scores":[149],"items":[153],"found":[154,189],"different":[155,210,236,243,252],"five-factor":[156],"solutions":[157],"assessment.":[167],"Confirmatory":[168],"modeling":[169],"indicated":[170],"these":[172],"models,":[173],"some":[175],"modifications,":[176],"fit":[177],"data":[179],"well.":[180],"At":[181],"endpoint,":[183],"however,":[184],"a":[185,220],"single-factor":[186],"solution":[187],"was":[188],"groups.":[194],"IMPLICATIONS:":[195],"Symptomatology":[196],"multifactorial":[201],"acute":[204],"state,":[207],"slightly":[209],"structures":[212],"episodes.":[217],"Following":[218],"single":[221],"severity":[222],"dimension":[223],"detected.":[225],"These":[226],"results":[227],"suggest":[228],"symptom":[230],"dimensions":[231],"mania":[233],"may":[234],"those":[238],"seen":[239],"where":[242],"elements":[244],"have":[247,251],"proven":[249],"functional":[253],"correlates":[254],"response.":[257]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}